Numerous investigations have demonstrated that Stat3 inhibition increases the effectiveness of chemotherapeutic drugs in OSCC [46,47] and that Stat3 hyperactivation is linked to tumor growth and treatment resistance [48,49]. Here, STAT3 is linked to neoplasm.